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Clinical use of radiotracer techniques in pediatric car-
diology is increasing. Three basic methods being em·
ployed are first pass radionuclide angiocardiography,
gated blood pool scanning and myocardial perfusion
scintigraphy. These methods are rapid, safe and accu-
rate. They are minimally invasive and result in a low
Three radionuclide methods are being applied in the field
of pediatric cardiology. These are first pass radionuclide
angiocardiography, gated blood pool scanning and myo-
cardial perfusion scintigraphy. Over the past few years,
there has been further progress and experience, both in the
technology and clinical applications of these radionuclide
techniques in children. These methods provide information
on cardiovascular dynamics, intra- and extracardiac shunts,
anatomy, myocardial function, myocardial perfusion and
chamber size and output. As radionuclide methods are safe,
accurate, rapid and minimally invasive, they continue to
gain acceptance among pediatric cardiologists. In this re-
view, we will discuss the clinical applications and meth-
odology of first pass radionuclide angiocardiography and
gated blood pool scanning in children. Myocardial imaging
is discussed elsewhere in this issue.
Radionuclide Angiocardiography
Clinical Applications
Radionuclide angiocardiography is performed in a few
minutes and it can be done on an outpatient basis or at the
bedside. It is a safe, accurate and relatively noninvasive
method. Results are available within a few minutes after
the examination.
Quantitation of left to right shunting is highly reliable
by first pass radionuclide angiocardiography (I). This tech-
nique also provides rapid and accurate estimation of right
and left ventricular ejection fraction and may assist in de-
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radiation dose to the patient. The development of ul-
trashort-lived radionuclides (such as iridium-191m with
a half-life of only 5 seconds), improvements in nuclear
imaging instrumentation and numerical analysis should
contribute to a further utilization of these methods.
(J Am Coil Cardiol1985,'5:120S-7S)
fining certain venous abnormalities, such as vena caval ob-
struction. There is great potential for further improvement
of this technique, including the introduction of ultrashort-
lived radionuclides and advances in instrumentation. Ultra-
short-lived radionuclides, such as iridium-191m, render this
technique even safer because they result in a significant
reduction in radiation absorbed dose to patients and permit
more convenient and precise interventional testing. Recent
improvements of gamma camera design allow better spatial
resolution and improved performance at the high count rates
that occur in first pass radionuclide angiocardiography.
Detection and quantitation of shunts are probably the
most frequent indications for radionuclide angiocardiogra-
phy in children. Results are accurate when compared with
those from more invasive techniques, and are more con-
sistent than results from most other noninvasive techniques.
Radionuclide angiocardiography provides a means to ac-
curately and serially monitor hemodynamic changes and can
help select those patients who need additional invasive pro-
cedures. In our institution, shunt quantitation by radio-
nuclide angiocardiography has supplanted cardiac catheter-
ization in the preoperative evaluation of some patients with
atrial septal defect. Other patients have been discharged
from further cardiac care on the basis of radionuclide eval-
uation. Children of all ages, including premature infants and
children immediately after surgery, can be evaluated easily
with these methods (2).
Radionuclide angiocardiography is useful in the diag-
nosis of residual defects or patch detachment, as in atrial
septal defect, ventricular septal defect or patent ductus ar-
teriosus. After the Mustard operation, radionuclide angio-
cardiography shows a characteristic pattern in the absence
of defects. This technique can detect residual defects, vena
caval obstruction and collateral circulation and also can
measure ventricular performance (3).
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Recently, we used first pass radionuclide angiocardiog-
raphy after the arterial switch operation in children with
transposition of the great vessels. In such patients, radio-
nuclide angiocardiography is useful in demonstrating right
and left ventricular function, myocardial perfusion and the
presence of shunts. In some of these patients, radionuclide
angiocardiography demonstrates nearly normal features. In
others, myocardial ischemia, infarction and ventricular dys-
function can be detected.
Measurement of left to right shunting in premature infants
with patent ductus arteriosus can be made while the patient
is in the neonatal intensive care unit using mobile equip-
ment, and can be accomplished without interrupting their
care. In these small infants, it is possible to diagnose spon-
taneous medical or surgical ductal closure. Radionuclide
angiocardiography can also be used in these patients after
surgery to detect additional, previously undiagnosed left to
right shunts or surgical failure (4,5).
We have found that iridium-191m radionuclide angio-
cardiography can be used reliably in the detection of left to
right shunting in infants. In nine such patients, there was
good agreement in the measurement of left to right shunting
with catheterization and iridium-191 m angiocardiography
(r= 0.90) (6).
Patients with ventricular septal defects and pulmonary
hypertension can also be evaluated with first pass radio-
nuclide angiocardiography to help assess their suitability for
surgery. Studies are performed first with the patient breath-
ing room air, and again after breathing an athmosphere rich
in oxygen. Increasing left to right shunt flow after breathing
oxygen indicates pulmonary vascular reactivity and, if of
sufficient magnitude, suggests that the patient is a candidate
for surgical correction. Unchanged left to right shunting
after breathing oxygen suggests fixed changes in the pul-
monary vasculature and a less favorable prognosis if the
ventricular septal defect is closed (7).
Adult patients with a clinical question of left to right
shunting through an atrial septal defect may be evaluated
with first pass radionuclide angiocardiography. Some of
these patients are asymptomatic, and a heart murmur is
discovered on a routine physical examination. Other patients
in this group present with increasing dyspnea with excercise.
In most cases, the diagnosis of left to right shunting or its
absence can be made rapidly and with confidence using
radionuclide angiocardiography. Right to left shunting can
be detected and quantified on technetium-99m first pass
radionuclide angiocardiography using intravenous xenon-
133 or technetium-99m macroaggregated albumin (8-10).
Recently, we have used first pass radionuclide angio-
cardiography in the evaluation of ventricular ejection frac-
tion in patients with cystic fibrosis, anomalous left coronary
artery from the pulmonary artery and cardiomyopathy. The
effect of excercise and therapy on ventricular performance
in children with cystic fibrosis is being evaluated. Also the
effect of adriamycin and other chemotherapeutic agents on
cardiac function is also being studied with this technique.
Methods
Radiopharmaceuticals. Technetium-99m. Technetium-
99m as sodium pertechnetate is the most commonly em-
ployed radiotracer in first pass radionuclide angiocardiog-
raphy. It has a physical half-life of 6 hours, and during its
decay emits a gamma ray of 140 keY. Intravascular indi-
cators, such as technetium-99m labeled to human serum
albumin or to red blood cells, are used if the first pass study
is performed just before a gated blood pool scan. Any other
technetium-99m-Iabeled radiopharmaceutical (except rna-
croaggregated albumin) may be used for this study provided
that the administered activity is adequate. Technetium-99m
diethylenetriamine pentaacetic acid (DTPA) may be used to
reduce body background in serial studies. The usual dose
of technetium-99m for first pass radionuclide angiocardiog-
raphy is 200 /Lei/kg body weight, with a minimal dose of
2 to 3 mCL The radiotracer must be in a volume of 1 ml
or less to permit the intravenous administration of a rapid
and compact bolus. The whole body radiation absorbed dose
for technetium-99m pertechnetate ranges from 0.110 rad in
infants to 0.182 rad in adults. The target organ (the organ
receiving the most radiation) in the case of pertechnetate is
the bowel, with an absorbed dose ranging from 1.3 rads in
infants to 2.8 rads in adult patients (5).
Iridium-191m. In recent years, we introduced iridium-
191m, a tracer with a physical half-life of only 5 seconds,
for first pass radionuclide angiocardiography (11). This ra-
diotracer is produced from an osmium-191~ iridium-191m
radionuclide generator. Osmium-191, the parent radio-
nuclide, has a physical half-life of 16 days. The radionuclide
generator can deliver multiple doses of iridium-191 m for 1
to 2 weeks. Advantages of iridium-191 m include a very low
radiation absorbed dose to patients, the capacity for repeated
studies within a short interval with negligible background
radiation and the ability to administer greater amounts of
activity than with technetium-99m. This radiotracer has been
used in detection and quantitation of shunts, estimation of
right and left ventricular ejection fraction and venography.
We used iridium-191m to examine more than 150 patients
ranging from premature infants to patients 60 years of age.
The whole body radiation absorbed dose with iridium-191 m
is 0.0035 and 0.0002 mradimCi in the newborn infant and
the adult patient, respectively. The radiation dose to the
vein in which the tracer is injected is about 4.0 mrad/mCi.
Examination technique. A computerized gamma cam-
era equipped with a high sensitivity collimator is used in
most children. In the evaluation of premature and newborn
infants, a high sensitivity, converging collimator is rec-
ommended because it provides a certain degree of magni-
fication which facilitates visual and quantitative evaluation
of these small angiograms. In the evaluation of ventricular
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ejection fraction, a high sensitivity collimator with slanted
holes is recommended. This collimator is positioned on
contact over the patient's chest to obtain a right anterior
oblique projection (12).
A single and small bolus of radiotracer is administered
intravenously and rapidly flushed with saline solution. One
of the external jugular veins is a recommended site of in-
jection. A butterfly type needle set is inserted in an external
jugular vein and flushed with a few milliliters of saline
solution to ensure good venous entry before the radiotracer
is injected. We use a disposable hand injector valve which
we had designed several years ago with good results (Valve
Check injection unit 56-10, Paramedical Instruments). In
most instances, this approach assures a rapid delivery of a
single bolus of tracer to the heart. The bolus should be
compact, lasting about 3 seconds, as judged by observing
a time-activity curve of the superior vena cava. If the bolus
of tracer is prolonged or fragmented, or both, temporal
resolution will be affected and the angiogram may yield
erroneous results. For example, the angiogram may suggest
a shunt when there is none, a shunt may be overestimated
or it may not be possible to estimate ventricular ejection
fraction. In the case of left to right shunts, deconvolution
analysis techniques, which correct for some imperfect in-
jections, have been developed (13,14).
First pass radionuclide angiocardiography is recorded on
the computer. For detection and quantitation of shunts, a
recording rate of 2 to 4 frames/s is adequate. Estimation
of ejection fraction requires rates of at least 20 frames/so
For shunt evaluation, a 25 second recording time is sufficient
in children; in adults, a 40 to 60 second study is suggested.
For calculation of cardiac output, a recording rate of I
frame/min for 5 minutes is used.
Intravenous technetium-99m macroaggregates of albu-
min have been employed in the detection and quantitation
of right to left shunts. Twenty to 50 fLCi/kgbody weight is
administered, and a scan of the whole body is obtained.
Although no adverse reactions have been reported from the
intravenous administration of macroaggregates, one should
remember that these particles produce microembolization
of systemic territories, including the brain and the kidneys.
Empirically for this study, we use a relatively small number
of particles (= 10,000).
Analysis. The angiogram is reviewed visually on a com-
puter monitor, and series of images of 0.5 to 2.0 seconds'
duration are photographed. Regions of interest over appro-
priate areas on the angiogram are selected, and their cor-
responding time-activity curves are calculated.
Normal radionuclide angiogram. A normal radionuclide
angiogram shows the passage of the radiotracer within the
superior or inferior vena cava, right atrium, right ventricle,
pulmonary artery, lungs, left atrium, left ventricle and aorta.
Pulmonary time-activity curves in the normal patient have
a characteristic appearance (Fig. 1).
Left to right shunting. In left to right shunting, the radio-
nuclide angiogram shows persistent levels of activity in the
lungs, with poor visualization of the left side of the heart
and the aorta due to dilution of the tracer by shunt recir-
culation. In small left to right shunts (pulmonary to systemic
flow ratio < 1.6), this may not be easily appreciated. This
dilution effect is accentuated with increasing shunt flow.
The pulmonary time-activity curve in left to right shunts
reveals an early secondary peak caused by premature re-
circulation of tracer in the lungs (Fig. 2).
A method for quantitating left to right shunts is based
on the analysis of pulmonary time-activity curves using a
gamma variate model. This method was developed in our
laboratory in 1973 (1). A gamma variate function is inter-
polated to the initial portion of the pulmonary curve. This
gamma function defines an area under the curve (area A),
Figure 1. Patient with a systolic murmur and a clinical question
of atrial septal defect or mild pulmonary stenosis. Normal tech-
netium-99m first pass radionuclide angiocardiogram in the anterior
projection. The study recorded at 2 frames/s is displayed so that
each frame represents 1.5 seconds. The series of images shows
the tracer as it circulates in the superior vena cava, right atrium,
right ventricle, lungs, left atrium, left ventricle and aorta. The
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Figure 2. Patient without symptoms discovered to have a heart
murmur on a routine physical examination. Anterior technetium-
99m radionuclide angiocardiogram showing a left to right shunt.
Each frame represents 1.5 seconds. The bolus of tracer delineates
the blood pools of the superior vena cava, right atrium, right
ventricle, pulmonary artery, lungs and left side of the heart. The
left side ofthe heart and the aorta, however, are not well visualized
because of the presence of activity within the right side of the
heart and the lungs. This persistent activity is due to early pul-
monary recirculation through the left to right shunt. Analysis of
the pulmonary curve reveals a shunt with a Qp:Qs ratio of 2.49.
which is proportional to the pulmonary blood flow (Qp).
This new curve is then subtracted from the remainder of the
pulmonary curve. Another gamma variate is interpolated to
the initial portion of the curve resulting from that subtrac-
tion. This new gamma variate defines an area (area B),
which is proportional to the amount of tracer returning to
the lungs (shunt flow). S\.Jbtracting area B from area A
results in a value proportional to the systemic flow (Qs). A
pulmonary to systemic flow ratio (Qp:Qs) is the equation
Qp:Qs = Area A/(Area A - Area B). This method yields
accurate estimates of shunt flow within a range of Qp:Qs
values from 1.2 to 3.0. Values of 1.0 to 1.2 may be found
in patients without shunting or with a very small left to right
shunt. Sh~nts having a Qp:Qs ratio greater than 3.0 are not
accurately calculated by this method (1). However, a Qp:Qs
ratio greater than 3.0 implies a very large shunt, obviating
the necessity for exact quantitation at this level. An invol-
untary Valsalva maneuver, severe pulmonary or tricuspid
regurgitation, significant bronchial or intercostal collateral
circulation (such as in patients with tetralogy of Fallot) and
severe heart failure are factors that may preclude accurate
quantitation of left to right shunting by this method.
Ideally, the radiotracer should be delivered to the car-
diovascular system as an instantaneous pulse because this
facilitates the application of the gamma variate method. In
practice, this is not always possible. However, it is possible
to estimate the pulmonary curve that would be produced
from an instantaneous pulse of tracer into the circulation by
using deconvolution analysis (13-15).
Right to left shunting. In right to left shunting, there is
a rapid passage of the tracer from the right to the left side
of the heart, with early visualization of the aorta. A left
ventricular time-activity curve in patients with a right to left
shunt reveals a,n initial peak of activity shunted from the
right to the left side of the heart, followed by another peak
corresponding to the fraction of radiotracer arriving in the
left ventricle after pulmonary circulation. Using an expo-
nential extrapolation of the downslopes afte: these two peaks,
shunt flow can be estimated by the ratio of the area under
the first peak to the area under both peaks (8,16).
Calculating the amount of right to left shunting after
intravenous administration of technetium-99m macroaggre-
gated albumin is relatively easy. The ratio of activity in the
pulmonary circulation and the systemic circulation will equal
the pulmonary to systemic flow ratio.
Right and left ventricular ejection fraction. In the cal-
culation of ventricular ejection fraction, regions of interest
are marked over the images of the right and left ventricles.
Time-activity curves from these regions are calculated and
displayed to identify the times within the study correspond-
ing to end-diastole and end-systole. If iridium-191m is used,
these curves are corrected for radioactive decay. We use a
low pass filter to eliminate high frequency noise. Consec-
utive frames at end-diastole and end-systole are selected
over several cardiac cycles during the first pass of radiotracer
within the right and left ventricles. Composite images of
end-diastole and end-systole are formed by adding the pre-
viously selected frames at the appropriate times (Fig. 3).
Subtracting the end-systolic images from the end-diastolic
images results in images that reflect the stroke volume of
each ventricle. These images are useful in outlining the
atrioventricular planes. Regions of interest for the right and
left end-diastolic and end-systolic ventricular margins are
outlined. Ventricular ejection fraction is then calculated by
the formula:
EF = (EDC - ESC)/EDC
EC '
where EF = left or right ventricular ejection fraction,
EDC = number of counts in the end-diastolic frame and
ESC = number of counts in the end-systolic frame.
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Figure 3. Patient with cystic fibrosis and heart failure. Right and
left ventricular ejection fraction determined by technetium-99m
first pass radionuclide angiography. Left panel, Right ventricular
phase. End-diastolic and end-systolic frames are represented. Right
ventricular ejection fraction is 27%. Center panel, Left ventricular
end-diastolic and end-systolic frames. Left ventricular ejection
fraction is 43%. Right panel, Right and left ventricular time-
activity curves.
Limitations with this method include relatively low tem-
poral resolution within the heart cycle, some difficulty in
detecting the edges of the ventricular blood pools and the
need for careful injection technique. However, this method
is rapid, accurate and ideally suited for children because a
long period of immobilization is not needed. An advantage
of this method over conventional angiocardiography and
echocardiography is that no assu.mptions are made about the
shape of the ventricles because estimation of ejection frac-
tion is based on the change in intraventricular count rate,
which is proportional to changes in volume. We have em-
ployed this method in children and compared it with con-
ventional angiocardiography in a small n!Imber of patients
and found a correlation coefficient of 0.91 (17). We also
measured left ventricular ejection fraction in a group of
normal children using first pass radionuclide angiocardiog-
raphy (17). Hurwitz et al. (18) measured right and left
ventricular ejection fractions in children who were referred
for skeletal scintigraphy and who had a normal cardiovas-
cular system. Values for normal ejection fractions in chil-
dren are shown in Table I.
Cardiac output, stroke volume, end-diastolic volumes
and pulmonary blood volume. Cardiac output can be cal-
culated by analysis of a time-activity curve generated from
a region of interest over the heart. A bolus of technetium-
99m red blood cells or technetium-99m human serum al-
bumin is given intravenously, and the computer is set to
record for about 5 minutes at a rate of 0.5 to 1.0 frames/so
Two initial peaks can be seen on the precordial curve; the
first peak corresponds to the tracer in the right side of the
heart and the second peak corresponds to the activity as it
circulates within the left side of the heart. After a few
minutes, the tracer will be in equilibrium within the cardiac
blood pool. An exponential extrapolation of the downslope
of the second peak defines an area (area A) corresponding
to the first pass of the indicator in the cardiac chambers.
An equilibrium value (e) is determined on the horizontal
portion of the cUfve. The total blood volume (TBY), which
is necessary for the calculation of cardiac output, is deter-
mined using either technetium-99m albumin or iridium-125
albumin. Cardiac output (CO) is calculated by the formula:
CO (ml/min) = TBV x e/A.
While the first two peaks represent intracardiac activity,
at equilibrium a portion of the activity arises outside the
intracardiac blood pool (chest wall, and so fortp). It has
been found that the value of cardiac output obtained from
the formula should be multiplied by 0.83 to correct for
extracardiac activity (19-21). We studied 17 infants and
children with simultaneous determinations of cardiac output
by radionuclide angiocardiography and oxygen consump-
tion at cardiac catheterization, and found a good agreement
by these two techniques (22).
Forward stroke volume (m!) is calculated by dividing the
cardiac output by the heart rate.
The end-diastolic volume of the left ventricle (ml) is
calculated by dividing the forward stroke volume by the left
ventricular ejection fraction.
The end-diastolic volume of the right side of the heart
Table 1. Mean Ventricular EjecHon Fraction Groupec:i According to Age of Patients
Age Patients Patients
(yr) (no.) RVEF (no.) LVEF
<I 5 0.54 ± 0.09 5 0.68 ± 0.13
1105 12 0.53 ± 0.07 II 0.62 ± 0.09
6to 10 16 0.52 ± 0.05 15 0.69 ± 0.08
11 to 15 19 0.54 ± 0.03 18 0.65 ± 0.09
16 to 20 22 0.53 ± 0.06 23 0.70 ± 0.08
Total 74 0.53 ± 0.06 72 0.68 ± 0.09
LVEF = left ventricular ejection fration; RVEF = right ventricular ejection fraction.





(m!) is equal to the cardiac output multiplied by the mean
transit time of the right heart.
The mean transit time of the right heart (MTTRH) is
calculated according to the equation:
!axtc (t) dt
MTTRH (seconds) = !coo ,
c (t) dt
o
where c (t) is the right ventricular time-activity curve ex-
ponentially extrapolated to the baseline.
The pulmonary blood volume (ml) is equal to the mean
pulmonary transit time multiplied by the cardiac output. The
mean pulmonary transit time is calculated as the mean transit
time between the right ventricle and the left atrium (16,
23-25).
Gated Blood Pool Scanning
Clinical Applications
The gated blood pool scan images the blood pool of the
heart by synchronizing the recording of the gamma camera,
with an indicator of cardiac contraction such as the R wave
of the electrocardiogram (Fig. 4). This technique permits
repetitive sampling of a specific phase of the cardiac cycle
from each of many cycles until an image of reasonable
quality is recorded. Certain conditions that should be met
for an adequate gated blood pool scan include constant car-
diac function, no patient motion, minimal diaphragmatic
motion, stable intravascular tracer and sufficient count den-
sity. This test permits the evaluation of global and regional
myocardial function. Generally, no patient preparation is
Figure 4. Patient with cardiomyopathy. Technetium-99m gated
blood pool scan in the left anterior oblique projection with the





required for this test; however, a few young patients require
sedation to keep them still for the 20 to 30 minutes needed
to record the study.
Several potential applications of gated blood pool scan-
ning in children have been proposed. These include mea-
surement of left and right ventricular ejection fraction, de-
termination of regurgitant fraction, measurement of left
ventricular volume and evaluation of ventricular wall motion.
This technique may be used to assess global ventricular
ejection fraction in infants and children, including those with
cystic fibrosis, cardiomyopathy and congenital heart disease
pre- and postoperatively. It has been shown (26) that in
patients with atrial septal defect in whom sequential gated
blood pool studies were performed before and after oper-
ation, there is right ventricular hypokinesia which persisted
after operation.
Assessment of global right ventricular function with gated
blood pool scans in patients with cystic fibrosis may be
difficult. This is especially true when the right ventricle is
very enlarged and its image overlaps that of the left ven-
tricle, even on carefully selected left anterior oblique
projections.
Focal myocardial wall motion abnormalities are unusual
problems in children. One cause of myocardial infarction
and abnormal wall motion is anomalous left coronary artery
originating from the pulmonary artery. When myocardial
infarction occurs in this condition, the segment of wall mo-
tion involved is usually quite large, such that its abnormal
motion can be detected by either gated blood pool scanning
or first pass radionuclide angiocardiography.
Focal abnormalities in wall motion can be seen in chil-
dren with other conditions, including mucocutaneous lumph
node syndrome, cardiomyopathy in thalassemia and tumors
of the heart.
Measurement of regurgitant fraction is possible with this
method by calculating the ratio of the change in the count
rate in the left ventricle (LV) from end-diastole to end-
1 FRAME/I2
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systole divided by the change in the count rate in the right
ventricle (RY) from end-systole to end-diastole (LY/RY
stroke volume ratio, regurgitant volume index). The mean
left ventricular to right ventricular stroke volume ratio in
normal patients is 1.19. In patients with aortic and or mitral
regurgitation, the stroke volume ratio is elevated. There is
a good agreement with this method and conventional an-
giographic grading of valvular regurgitation. This technique
is simple and does not require elaborate data processing. In
our laboratory, the stroke volume ratio in normal subjects
varied from 1.0 to 1.3. After corrective surgery, in patients
with mitral or aortic regurgitation, or both, the stroke vol-
ume ratio decreases. A stroke volume ratio greater than 2.0
is compatible with moderately severe regurgitation, and a
ratio greater than 3.0 suggests severe regurgitation. This
method should be useful in defining the clinical course of
young patients with left-sided valvular regurgitation (27,28).
Methods
Radiopharmaceuticals. Technetium-99m red blood cells
or Tc-99m human serum albumin may be used. A usual dose
of these tracers is 300 /LCi/kg body weight, with a minimal
dose of 2 to 3 mCi. We use technetium-99m red blood cells
that are labeled in vitro using a pediatric version of the
Brookhaven National Laboratory kit for labeling patient's
red blood cells (29).
Examination technique. We use a computerized gamma
camera equipped with a slanted hole collimator. Patients
are examined in the supine position with the appropriate
connections for the electrocardiogram in place. The colli-
mator is placed in contact with the patient's chest wall in
a left anterior oblique projection, with the collimator holes
pointing caudally. The obliquity is changed until the right
and left ventricular blood pools are clearly separated. This
collimator produces some spatial distortion; however, this
does not seem to significantly affect the estimation of left
ventricular volume. In newborns and infants, we employ a
coverging or a pinhole collimator.
At least 20 frames are recorded within each cardiac cycle,
and usually 20 to 30 minutes are necessary to complete one
study. Each study is recorded for 5 to 10 million counts.
Patients with severe arrhythmias, such as atrial fibrillation,
may not be studied with this technique. Minor arrhythmias
with a change in the RR interval of about 100 ms can be
studied. Alternatively, it is possible to record all scinti-
graphic events along with a digitized electrocardiogram us-
ing the list recording mode, and then evaluate various RR
intervals.
Analysis. Before analyzing the gated blood pool scan,
it is important to assess the technical adequacy of the study.
The following items should be examined: adequate tracer
labeling, positioning, sharpness of the image and adequate
gating. The study is then evaluated visually on a cinematic
display and on a series of timed images. Time-activity curves
are calculated for the left ventricle, right ventricle and back-
ground. From these curves, it is possible to calculate a
number of values including ejection fraction, ejection rate
and filling rate. Left ventricular volume can be estimated
with the usual geometric measurements.
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